China Pharma Holdings, Inc. (CPHI)
USD 0.17
(-9.78%)
USD 0.17
(-9.78%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 7.01 Million | 8.1 Million | 9.64 Million | 10.86 Million | 10.92 Million | 12.33 Million |
| Cost of Revenue | 7.51 Million | 8.59 Million | 9.29 Million | 8.91 Million | 9.44 Million | 10.35 Million |
| Gross Profit | -504.88 Thousand | -493.91 Thousand | 349.27 Thousand | 1.95 Million | 1.48 Million | 1.97 Million |
| Operating Expenses | 2.47 Million | 3.14 Million | 3.46 Million | 4.41 Million | 4.87 Million | -12.42 Million |
| Selling, General and Administrative Expenses | 2.24 Million | 2.86 Million | 3.14 Million | 4.03 Million | 4.64 Million | 5.77 Million |
| Research and Development Expenses | 240.08 Thousand | 185.85 Thousand | 318.96 Thousand | 377.96 Thousand | 229.63 Thousand | 172.38 Thousand |
| Other Expenses | - | 93.85 Thousand | - | 115.18 Billion | 7576.51 Billion | - |
| Cost and Expenses | 9.76 Million | 5.54 Million | 12.75 Million | 13.32 Million | 14.31 Million | -2.06 Million |
| Operating Income | -2.75 Million | -3.54 Million | -3.11 Million | -2.45 Million | -3.38 Million | -3.96 Million |
| Interest Expense | 333.6 Thousand | 434.61 Thousand | 542 Thousand | 294.15 Thousand | 321.71 Thousand | 451.25 Thousand |
| Income Tax Expense | - | 6.24 Million | 542 Thousand | 294.15 Thousand | 321.71 Thousand | 109.98 Thousand |
| Earnings before Tax | -3.07 Million | -3.97 Million | -3.39 Million | -2.86 Million | -20.7 Million | -10.86 Million |
| Net Income | -3.07 Million | -10.22 Million | -3.94 Million | -3.16 Million | -21.02 Million | -10.75 Million |
| Earnings Per Share Basic | -0.91 | -1.94 | -0.85 | -0.72 | -4.82 | -2.47 |
| Earnings Per Share Diluted | -0.91 | -1.94 | -0.85 | -0.72 | -4.82 | -2.47 |
| Weighted Average Shares Outstanding | 3.38 Million | 5.25 Million | 4.61 Million | 4.36 Million | 4.35 Million | 4.35 Million |
| Weighted Average Shares Outstanding (Diluted) | 3.38 Million | 5.25 Million | 4.61 Million | 4.36 Million | 4.35 Million | 4.35 Million |
| Gross Margin | -0.07 | -0.06 | 0.04 | 0.18 | 0.14 | 0.16 |
| EBIT Margin | 0.00 | -0.10 | -0.00 | 0.02 | -0.04 | -0.06 |
| Profit Margin | -0.44 | -1.26 | -0.41 | -0.29 | -1.92 | -0.87 |
| EBITDA | 8436.00 | -837.68 Thousand | 230.34 Thousand | 106.85 Thousand | -17.45 Million | -7.15 Million |
| Earnings Before Tax Margin | -0.39 | -0.44 | -0.32 | -0.23 | -0.31 | -0.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 924.94 Thousand | 1.36 Million | 2.14 Million | 7.01 Million | 1.8 Million | 1.09 Million |
| Cost of Revenue | 2.04 Million | 1.65 Million | 2.29 Million | 7.51 Million | 2.03 Million | 1.24 Million |
| Gross Profit | -1.12 Million | -290.02 Thousand | -141.41 Thousand | -504.88 Thousand | -233.19 Thousand | -146.66 Thousand |
| Operating Expenses | 271.21 Thousand | 628.09 Thousand | 1.04 Million | 2.24 Million | 498.56 Thousand | 305.6 Thousand |
| Selling, General and Administrative Expenses | 106.87 Thousand | 596.64 Thousand | 895.52 Thousand | - | 452.79 Thousand | 281.85 Thousand |
| Research and Development Expenses | 164.33 Thousand | 31.45 Thousand | 147.55 Thousand | - | 45.77 Thousand | 23.74 Thousand |
| Other Expenses | 8.47 Billion | - | -4.04 Billion | - | - | 4.04 Billion |
| Cost and Expenses | 2.31 Million | 2.28 Million | 3.33 Million | 9.76 Million | 2.53 Million | 1.55 Million |
| Operating Income | -1.39 Million | -916.05 Thousand | -1.18 Million | -2.75 Million | -713.54 Thousand | -456.3 Thousand |
| Interest Expense | 48.14 Thousand | -42.15 Thousand | 50.25 Thousand | 333.6 Thousand | -66.24 Thousand | 137.66 Thousand |
| Income Tax Expense | -3.00 | -733.79 Thousand | 3.00 | -4.00 | -683.09 Thousand | 137.66 Thousand |
| Earnings before Tax | -1.43 Million | -955.89 Thousand | -1.23 Million | -3.07 Million | -777.6 Thousand | -593.02 Thousand |
| Net Income | -1.43 Million | -955.89 Thousand | -1.23 Million | -3.07 Million | -777.6 Thousand | -593.02 Thousand |
| Earnings Per Share Basic | -0.09 | -0.07 | -0.12 | - | -0.07 | -0.06 |
| Earnings Per Share Diluted | -0.09 | -0.07 | -0.12 | - | -0.07 | -0.06 |
| Weighted Average Shares Outstanding | 16.12 Million | 13.13 Million | 10.62 Million | 3.38 Million | 10.57 Million | 9.91 Million |
| Weighted Average Shares Outstanding (Diluted) | 16.12 Million | 13.13 Million | 10.62 Million | 3.38 Million | 10.57 Million | 9.91 Million |
| Gross Margin | -1.21 | -0.21 | -0.07 | -0.07 | -0.13 | -0.13 |
| EBIT Margin | -0.70 | -0.67 | -0.23 | - | -0.40 | 0.22 |
| Profit Margin | -1.55 | -0.70 | -0.57 | -0.44 | -0.43 | -0.54 |
| EBITDA | -649.88 Thousand | -916.05 Thousand | -488.65 Thousand | - | -713.54 Thousand | 243.52 Thousand |
| Earnings Before Tax Margin | -1.50 | -0.67 | -0.55 | -0.39 | -0.40 | -0.42 |
JEGI
2791
MED
0618
5367
3297